Randomized Phase III-Study in Stage IIIb and IV Non-Small-Cell Lung Cancer. Sequential Single-Agent vs. Double-Agent vs. Triple-Agent Therapy.

NCT00148395 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

280

Enrollment

OTHER

Sponsor class

Conditions

Non-Small-Cell Lung Carcinoma

Interventions

DRUG: Gemcitabine
DRUG: Navelbine
DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Mitomycin
DRUG: Ifosfamide

Sponsor

Aktion Bronchialkarzinom e.V.